Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 8, 2025BJC ReportsOpen Access

Germline JAK2 R564Q variants presenting as hereditary thrombocytosis: case report

View Full Paper
Ask AI
Bookmark
Share

Authors

SFStephanie FrancoKKKinga KrawiecPSPiotr Strzałka

Discussion

Loading...

Member takes

Overview

Case report reveals three individuals with JAK2 R564Q variants, indicating potential hereditary thrombocytosis risk.

Key Points

  • Germline JAK2 R564Q variants lead to hereditary thrombocytosis in three unrelated individuals, providing new insights into this disorder.
  • Among the three cases, two variants were classified as uncertain and one as likely pathogenic, highlighting classification discrepancies.
  • This report advocates for germline testing in young MPN patients and those with familial disease, emphasizing hereditary risks.
  • The findings aim to solidify the understanding of R564Q pathogenicity, supporting its potential designation as a significant variant.

Cite This Study

Franco et al. (2025) studied this question.

synapsesocial.com/papers/68e6860af44b9035634c2022https://doi.org/10.1038/s44276-025-00186-7
View Full Paper
Ask AI
Bookmark
Share